The Effect of XSurge Supplementation on Biomarkers and Performance From High Intensity Resistance Exercise

Completed · Not applicable · Has a placebo group

Conditions studied: Exercise Performance Recovery

In brief

Part one of this study will consist of baseline (BL) testing, 28 days of daily supplementation with XSurge, and an exercise protocol. The acute exercise protocol consists of five visits, of which, the first visit will consist of maximal strength testing. The remaining visits will consist of performance testing and muscle evaluation. Phase two of this study will consist of six weeks of supervised resistance training along with supplementation of XSurge. Following the six weeks of training, subjects will complete a second acute exercise protocol. Measures to be evaluated will consist of performance testing and muscle evaluation.

Key facts

Study ID

NCT02442245

Run by

Kemin Foods LC

People needed

41

Starts

2015-02-01

Expected to finish

2016-08-01

Last updated by the study team

2018-01-31

Who can join

Age: 18 and older, up to 35. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Recreationally active.
• Subject is judged by the Investigator to be healthy and free of any physical limitations
• Subject is male 18-35 y of age, inclusive
• Subject has a body mass index of 18.0-34.9 kg/m2
• Subject is willing to maintain habitual diet
• Subject is willing to abstain from dietary supplementation
• Subject understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators

You may not qualify if…

• Subject is currently or will be enrolled in another clinical trial.
• Subject has a history or presence of a clinically relevant cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder.
• Subject has a history or presence of cancer in the prior 2 years, except for non-melanoma skin cancer.
• Subject is unable to perform physical exercise
• Subject is a current smoker or has quit within the last 6 months
• Subject is engaged in an extreme diet including but not limited to, Atkins, South Beach, Intermittent Fasting, etc.
• Subject is allergic to the study product or placebo
• Subject is taking any other nutritional supplement or performance enhancing drug
• Subjects that have donated blood or plasma within the previous week
• Subject has any chronic illness that causes continuous medical care
• Taking any type of prescription or over-the-counter medication including but not limited to corticosteroids, non-steroidal anti-inflammatory drugs, and antibiotics within the 14 days prior to the screening visit.

Where it is running

• University of Central Florida — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.